Clinical Trial

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

Name: Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML — clinical trial record (NCT07338357)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

A study to evaluate the safety and preliminary efficacy of CLL-1-targeted CAR-T cell therapy in children aged 3 to 18 years with relapsed or refractory acute myeloid leukemia (r/r AML).

Trial Details

NCT Number	NCT07338357
Lead Sponsor	First Affiliated Hospital of Guangxi Medical University Collaborators: Guangzhou Bio-gene Technology Co., Ltd
Conditions	AML (Acute Myeloid Leukemia), CAR-T
Enrollment	10 participants
Start Date	2026-01-05
Primary Completion	2028-10-31 (estimated)
Study Completion	2028-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-13